It is a pilot study aimed to determine if oral Mucinex® is effective in reducing the amount
of corneal filaments and improving symptomology in subjects with filamentary keratitis.
Phase:
N/A
Details
Lead Sponsor:
Massachusetts Eye and Ear Infirmary
Treatments:
Chlorpheniramine, phenylpropanolamine drug combination Guaifenesin Phenylpropanolamine